IPSC Projected Dividend Yield
Century Therapeutics Inc ( NASDAQ : IPSC )Century Therapeutics is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with unmet medical need. Co.'s primary product candidate, CNTY-101, is an allogeneic, chimeric antigen receptors (CAR)-induce pluripotent stem cell-derived (iPSC-derived) natural killer (iNK) cell therapy that has been engineered to express CD19 CAR, soluble IL-15, an epidermal growth factor receptor safety switch, and also contains gene edits needed to incorporate Allo-Evasion™ technology. CNTY-103 is Co.'s main product candidate targeting a solid tumor. 20 YEAR PERFORMANCE RESULTS |
IPSC Dividend History Detail IPSC Dividend News IPSC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |